PROTAGENIC THERAPEUTICS INC (PTIX) Stock Balance Sheet
NASDAQ:PTIX - Nasdaq - US74365N2027 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.06M | 1.29M | 220.00K | 540.00K | 670.00K | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | N/A | |||
| Marketable Securities | N/A | 2.77M | 7.76M | 9.83M | N/A | |||
| Other Current Assets | 366.90K | 144.03K | 60.00K | 690.00K | 210.00K | |||
| Total Current Assets | 1.42M | 4.20M | 8.04M | 11.06M | 880.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 85.62K | 123.33K | 0.00 | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 85.62K | 123.33K | 0.00 | 0.00 | 0.00 | |||
| TOTAL ASSETS | 1.51M | 4.32M | 8.04M | 11.06M | 880.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 340.00K | 0.00 | 0.00 | |||
| Accrued Expenses | N/A | 113.80K | 160.00K | 280.00K | 140.00K | |||
| Accounts Payable | 789.32K | 541.45K | 620.00K | 520.00K | 430.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 80.00K | |||
| Total Current Liabilities | 789.32K | 655.25K | 1.12M | 800.00K | 660.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 320.00K | 1.37M | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 320.00K | 1.37M | |||
| TOTAL LIABILITIES | 789.32K | 655.25K | 1.12M | 1.12M | 2.03M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -34.75M | -30.78M | -25.78M | -22.22M | -17.70M | |||
| Additional Paid In Capital | 35.60M | 34.56M | 33.37M | 32.41M | 16.72M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 480.00 | 440.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -130.25K | -113.55K | -680.00K | -250.00K | -170.00K | |||
| Shares Outstanding | 4.80M | 4.44M | 4.32M | 4.30M | 2.59M | |||
| Tangible Book Value per Share | 0.15 | 0.83 | 1.60 | 2.31 | -0.44 | |||
| Total Shareholders' Equity | 719.01K | 3.67M | 6.92M | 9.94M | -1.15M | |||
| TOTAL LIABILITIES AND EQUITY | 1.51M | 4.32M | 8.04M | 11.06M | 880.00K | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.03 | -1.19 | |||
| Current Ratio | 1.80 | 6.41 | 7.18 | 13.82 | 1.33 | |||
| Return On Assets (ROA) | -374.44% | -115.66% | -44.78% | -40.69% | -284.09% | |||
| Return On Equity (ROE) | -785.49% | -136.32% | -52.02% | -45.27% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21